Background: Testicular cancer (TC) incidence has risen globally, yet population-based net survival and flexible parametric modeling across histological subtypes in Spain remain insufficiently characterized. Methods: Incident TC cases (1993–2017) were obtained from the Spanish Network of Cancer Registries (REDECAN). Age-standardized incidence rates (ASIR, 2013 European standard) and temporal trends (Joinpoint regression APC) were analyzed by age and histology, including seminomatous germ cell tumors (SGCTs), nonseminomatous germ cell tumors (NSGCTs), and others. Five-year overall survival (OS, Kaplan-Meier) and net survival (NS, Pohar-Perme, ICSS-3 standardized) for 2000–2017 were evaluated. Multivariable flexible parametric models estimated excess hazard ratio (EHR) of mortality. Results: A total of 5,582 cases were analyzed. ASIR increased from 2.31 per 100,000 in 1993–2000 to 5.08 in 2010–2017 (APC=4.6, 95%CI: 4.1; 5.3). Five-year OS and NS reached 94.3% and 95.9% in 2009–2017, respectively. SGCTs demonstrated superior 5-year NS (97.1%) compared to NSGCTs (91.6%) and others (87.8%). Multivariable flexible models revealed significantly higher excess mortality for age ≥40 years (EHR=3.28, 95%CI: 1.95; 5.52 vs 15–24 years), NSGCTs (EHR=4.20, 95%CI: 2.79; 6.30 vs SGCTs), and 'Others' (EHR=5.77), while survival improved in 2009–2017 (EHR=0.70, 95%CI: 0.51; 0.96). Conclusions: TC incidence in Spain more than doubled over 25 years. Survival is generally excellent but exhibits marked disparities by histology and age, emphasizing the need for age-tailored clinical management.